Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 38 | $16,714,672 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Nov 2024 16:39 | KNSA | Kiniksa Pharmaceuticals International plc | TESSARI EBEN | CHIEF OPERATING OFFICER | 18 Nov 2024 | Sale | 17,000 | 21.04 | 357,680 | D |
| 08 Nov 2024 16:34 | KNSA | Kiniksa Pharmaceuticals International plc | PATEL SANJ K | CHAIRMAN & CEO | 06 Nov 2024 | Sale | 89,561 | 23 | 2,059,903 | D |
| 17 Oct 2024 16:35 | KNSA | Kiniksa Pharmaceuticals International plc | TESSARI EBEN | CHIEF OPERATING OFFICER | 15 Oct 2024 | Sale | 17,000 | 26.87 | 456,790 | D |
| 25 Sep 2024 16:39 | KNSA | Kiniksa Pharmaceuticals International plc | TESSARI EBEN | CHIEF OPERATING OFFICER | 23 Sep 2024 | Sale | 17,500 | 24.99 | 437,325 | D |
| 04 Sep 2024 20:52 | KNSA | Kiniksa Pharmaceuticals International plc | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 03 Sep 2024 | Sale | 1,478 | 27.13 | 40,098 | D |
| 04 Sep 2024 20:52 | KNSA | Kiniksa Pharmaceuticals International plc | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 03 Sep 2024 | Sale | 59,214 | 26.09 | 1,544,893 | D |
| 04 Sep 2024 20:42 | KNSA | Kiniksa Pharmaceuticals International plc | MOAT ROSS | CHIEF COMMERCIAL OFFICER | 03 Sep 2024 | Sale | 1,160 | 27.12 | 31,459 | D |
| 04 Sep 2024 20:42 | KNSA | Kiniksa Pharmaceuticals International plc | MOAT ROSS | CHIEF COMMERCIAL OFFICER | 03 Sep 2024 | Sale | 67,346 | 26.1 | 1,757,731 | D |
| 29 Aug 2024 16:36 | KNSA | Kiniksa Pharmaceuticals International plc | TESSARI EBEN | CHIEF OPERATING OFFICER | 27 Aug 2024 | Sale | 17,500 | 26.91 | 470,925 | D |
| 25 Jul 2024 16:33 | KNSA | Kiniksa Pharmaceuticals International plc | PATEL SANJ K | CHAIRMAN & CEO | 23 Jul 2024 | Sale | 63,049 | 27.01 | 1,702,953 | D |
| 25 Jul 2024 16:33 | KNSA | Kiniksa Pharmaceuticals International plc | PATEL SANJ K | CHAIRMAN & CEO | 23 Jul 2024 | Sale | 50,000 | 25.05 | 1,252,500 | D |
| 25 Jul 2024 16:33 | KNSA | Kiniksa Pharmaceuticals International plc | PATEL SANJ K | CHAIRMAN & CEO | 23 Jul 2024 | Sale | 23,075 | 23.25 | 536,494 | D |
| 25 Jul 2024 16:32 | KNSA | Kiniksa Pharmaceuticals International plc | RAGOSA MARK | CHIEF FINANCIAL OFFICER | 23 Jul 2024 | Sale | 24,248 | 24.79 | 601,108 | D |
| 25 Jul 2024 16:31 | KNSA | Kiniksa Pharmaceuticals International plc | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 23 Jul 2024 | Sale | 100 | 27.87 | 2,787 | D |
| 25 Jul 2024 16:31 | KNSA | Kiniksa Pharmaceuticals International plc | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 23 Jul 2024 | Sale | 8,446 | 27.1 | 228,887 | D |
| 25 Jul 2024 16:31 | KNSA | Kiniksa Pharmaceuticals International plc | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 23 Jul 2024 | Sale | 7,924 | 26.36 | 208,877 | D |
| 25 Jul 2024 16:31 | KNSA | Kiniksa Pharmaceuticals International plc | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 23 Jul 2024 | Sale | 5,530 | 25.03 | 138,416 | D |
| 11 Mar 2024 19:05 | KNSA | Kiniksa Pharmaceuticals Ltd. | PATEL SANJ K | CHAIRMAN & CEO | 07 Mar 2024 | Sale | 65,012 | 21.02 | 1,366,552 | I |
| 06 Mar 2024 17:37 | KNSA | Kiniksa Pharmaceuticals Ltd. | PATEL SANJ K | CHAIRMAN & CEO | 06 Mar 2024 | Sale | 5,582 | 21 | 117,222 | I |
| 06 Mar 2024 17:37 | KNSA | Kiniksa Pharmaceuticals Ltd. | PATEL SANJ K | CHAIRMAN & CEO | 04 Mar 2024 | Sale | 3,336 | 22 | 73,392 | I |
| 06 Mar 2024 17:37 | KNSA | Kiniksa Pharmaceuticals Ltd. | PATEL SANJ K | CHAIRMAN & CEO | 04 Mar 2024 | Sale | 9,406 | 21.31 | 200,442 | I |
| 05 Mar 2024 16:34 | KNSA | Kiniksa Pharmaceuticals Ltd. | TESSARI EBEN | CHIEF OPERATING OFFICER | 01 Mar 2024 | Sale | 1,189 | 22.03 | 26,194 | D |
| 05 Mar 2024 16:31 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 01 Mar 2024 | Sale | 18,844 | 21.77 | 410,234 | D |
| 01 Mar 2024 18:26 | KNSA | Kiniksa Pharmaceuticals Ltd. | MEGNA MICHAEL R | CHIEF ACCOUNTING OFFICER | 01 Mar 2024 | Sale | 9,659 | 21.45 | 207,186 | D |
| 01 Mar 2024 18:26 | KNSA | Kiniksa Pharmaceuticals Ltd. | MEGNA MICHAEL R | CHIEF ACCOUNTING OFFICER | 28 Feb 2024 | Sale | 5,126 | 21.79 | 111,696 | D |
| 29 Feb 2024 16:26 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 27 Feb 2024 | Sale | 10,156 | 21.03 | 213,581 | D |
| 04 Jan 2024 16:30 | KNSA | Kiniksa Pharmaceuticals Ltd. | RAGOSA MARK | CHIEF FINANCIAL OFFICER | 03 Jan 2024 | Sale | 12,000 | 20 | 240,000 | D |
| 04 Jan 2024 16:30 | KNSA | Kiniksa Pharmaceuticals Ltd. | MEGNA MICHAEL R | CHIEF ACCOUNTING OFFICER | 02 Jan 2024 | Sale | 16,670 | 19.17 | 319,564 | D |
| 21 Dec 2023 16:26 | KNSA | Kiniksa Pharmaceuticals Ltd. | MEGNA MICHAEL R | CHIEF ACCOUNTING OFFICER | 19 Dec 2023 | Sale | 9,316 | 19.13 | 178,215 | D |
| 11 Dec 2023 16:20 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 07 Dec 2023 | Sale | 6,702 | 17.75 | 118,960 | D |
| 11 Dec 2023 16:20 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 07 Dec 2023 | Sale | 1,501 | 17.81 | 26,733 | D |
| 11 Dec 2023 16:20 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 07 Dec 2023 | Sale | 13,017 | 17.64 | 229,620 | D |
| 11 Dec 2023 16:20 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 07 Dec 2023 | Sale | 7,380 | 17.54 | 129,445 | D |
| 06 Sep 2023 19:03 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 05 Sep 2023 | Sale | 400 | 17.53 | 7,012 | D |
| 27 Jul 2023 16:30 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 25 Jul 2023 | Sale | 7,632 | 19.69 | 150,274 | D |
| 27 Jul 2023 16:30 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 25 Jul 2023 | Sale | 16,168 | 19.25 | 311,234 | D |
| 27 Jul 2023 16:30 | KNSA | Kiniksa Pharmaceuticals Ltd. | PAOLINI JOHN F. | CHIEF MEDICAL OFFICER | 25 Jul 2023 | Sale | 5,200 | 18.01 | 93,652 | D |
| 01 Dec 2022 16:16 | KNSA | Kiniksa Pharmaceuticals Ltd. | QUART BARRY D | Director | 29 Nov 2022 | Sale | 21,959 | 16.15 | 354,638 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)